NEUROLOGY

January 18, 2024

Treating Genetic Obesity With the Novel Agent Setmelanotide

This drug, which has had favorable results in clinical trials, is indicated only for use in obese patients who have specific genetic disorders.
January 18, 2024

Alzheimer’s Disease

January 18, 2024

Plantar Fasciitis

January 18, 2024

Neurology News Digest

October 18, 2023

New Drug Review 2023

October 18, 2023

An Overview of Down Syndrome

June 16, 2023

Tardive Dyskinesia